Key facts
- Laurence W. Lytton filed SCHEDULE 13G/A for Cellectar Biosciences, Inc. Common Stock (CLRB).
- Disclosed ownership: 1.6%.
- Date of event: 30 Jun 2025.
Laurence W. Lytton - 30 Jun 2025 SCHEDULE 13G/A Report for Cellectar Biosciences, Inc. Common Stock (CLRB)
- Filing Manager
- Laurence W. Lytton
- Reporting Manager
- LYTTON LAURENCE W
- Symbol
- CLRB
- Shares outstanding
- 3,211,938 shares
- Disclosed Ownership
- 51,391 shares
- Ownership
- 1.6%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Aug 2025, 18:12:37 UTC
- Date of event
- 30 Jun 2025
- SEC
- View on sec.gov
Key filing fact
Laurence W. Lytton disclosed 1.6% ownership in Cellectar Biosciences, Inc. Common Stock (CLRB) on 30 Jun 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Aug 2025, 18:12.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (1)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| LYTTON LAURENCE W | 1.6% | 51,391 | 51,391 | 0 | /s/ Laurence W. Lytton | Reporting person |
CIK / CUSIP context first